Kendall Bell, MD | |
310 S Limestone, Lexington, KY 40508-3008 | |
(859) 252-6612 | |
Not Available |
Full Name | Kendall Bell |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 40 Years |
Location | 310 S Limestone, Lexington, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326040932 | NPI | - | NPPES |
64240971 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 24097 (Kentucky) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Commonwealth Anesthesia, Psc | 5092627521 | 180 |
News Archive
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
› Verified 9 days ago
Entity Name | Commonwealth Anesthesia, Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437196300 PECOS PAC ID: 5092627521 Enrollment ID: O20031104000115 |
News Archive
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
› Verified 9 days ago
Entity Name | Triangle Anesthesia Group, Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124079314 PECOS PAC ID: 9436161585 Enrollment ID: O20060608000180 |
News Archive
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
› Verified 9 days ago
Entity Name | Riverside Anesthesia Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578946596 PECOS PAC ID: 3072828193 Enrollment ID: O20150819007441 |
News Archive
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Kendall Bell, MD 425 Lewis Hargett Cir, Lexington, KY 40503-3590 Ph: (859) 268-1030 | Kendall Bell, MD 310 S Limestone, Lexington, KY 40508-3008 Ph: (859) 252-6612 |
News Archive
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
› Verified 9 days ago
Harish Ram, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-323-1080 | |
Ashley Erin Green, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose Street Anesthesiology, Lexington, KY 40536 Phone: 859-218-0069 | |
Mihaela Cornea, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Joseph Dr, Lexington, KY 40504 Phone: 859-313-1000 | |
Justin Kirby Wainscott, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-323-1080 | |
John Little, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 150 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-967-5000 | |
Riley Joseph Woolford, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose Street, N202, Lexington, KY 40536 Phone: 859-323-5956 | |
Dr. Richard B Mccreary, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1101 Veterans Dr, Lexington, KY 40502 Phone: 859-281-4906 |